|
Fusion gene ID: 23122 |
FusionGeneSummary for MYO1B_ITGAV |
Fusion gene summary |
Fusion gene information | Fusion gene name: MYO1B_ITGAV | Fusion gene ID: 23122 | Hgene | Tgene | Gene symbol | MYO1B | ITGAV | Gene ID | 4430 | 3685 |
Gene name | myosin IB | integrin subunit alpha V | |
Synonyms | MMI-alpha|MMIa|MYH-1c|myr1 | CD51|MSK8|VNRA|VTNR | |
Cytomap | 2q32.3 | 2q32.1 | |
Type of gene | protein-coding | protein-coding | |
Description | unconventional myosin-IbMYO1B variant proteinmyosin-I alpha | integrin alpha-Vantigen identified by monoclonal antibody L230integrin alphaVbeta3integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51)vitronectin receptor subunit alpha | |
Modification date | 20180522 | 20180520 | |
UniProtAcc | O43795 | P06756 | |
Ensembl transtripts involved in fusion gene | ENST00000339514, ENST00000392318, ENST00000304164, ENST00000392316, ENST00000439065, ENST00000496992, | ENST00000261023, ENST00000374907, ENST00000433736, ENST00000474571, | |
Fusion gene scores | * DoF score | 10 X 9 X 5=450 | 4 X 4 X 3=48 |
# samples | 10 | 4 | |
** MAII score | log2(10/450*10)=-2.16992500144231 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/48*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: MYO1B [Title/Abstract] AND ITGAV [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | ITGAV | GO:0007155 | cell adhesion | 10218736 |
Tgene | ITGAV | GO:0008284 | positive regulation of cell proliferation | 19578119 |
Tgene | ITGAV | GO:0033627 | cell adhesion mediated by integrin | 12807887|17158881 |
Tgene | ITGAV | GO:0034446 | substrate adhesion-dependent cell spreading | 24658351 |
Tgene | ITGAV | GO:0045785 | positive regulation of cell adhesion | 10708943 |
Tgene | ITGAV | GO:0050764 | regulation of phagocytosis | 10570297 |
Tgene | ITGAV | GO:0070588 | calcium ion transmembrane transport | 18395422 |
Tgene | ITGAV | GO:2000536 | negative regulation of entry of bacterium into host cell | 10570297 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | LIHC | TCGA-UB-A7MA-01A | MYO1B | chr2 | 192110337 | + | ITGAV | chr2 | 187487066 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5UTR-3CDS | ENST00000339514 | ENST00000261023 | MYO1B | chr2 | 192110337 | + | ITGAV | chr2 | 187487066 | + |
5UTR-3CDS | ENST00000339514 | ENST00000374907 | MYO1B | chr2 | 192110337 | + | ITGAV | chr2 | 187487066 | + |
5UTR-3CDS | ENST00000339514 | ENST00000433736 | MYO1B | chr2 | 192110337 | + | ITGAV | chr2 | 187487066 | + |
5UTR-intron | ENST00000339514 | ENST00000474571 | MYO1B | chr2 | 192110337 | + | ITGAV | chr2 | 187487066 | + |
5UTR-3CDS | ENST00000392318 | ENST00000261023 | MYO1B | chr2 | 192110337 | + | ITGAV | chr2 | 187487066 | + |
5UTR-3CDS | ENST00000392318 | ENST00000374907 | MYO1B | chr2 | 192110337 | + | ITGAV | chr2 | 187487066 | + |
5UTR-3CDS | ENST00000392318 | ENST00000433736 | MYO1B | chr2 | 192110337 | + | ITGAV | chr2 | 187487066 | + |
5UTR-intron | ENST00000392318 | ENST00000474571 | MYO1B | chr2 | 192110337 | + | ITGAV | chr2 | 187487066 | + |
5UTR-3CDS | ENST00000304164 | ENST00000261023 | MYO1B | chr2 | 192110337 | + | ITGAV | chr2 | 187487066 | + |
5UTR-3CDS | ENST00000304164 | ENST00000374907 | MYO1B | chr2 | 192110337 | + | ITGAV | chr2 | 187487066 | + |
5UTR-3CDS | ENST00000304164 | ENST00000433736 | MYO1B | chr2 | 192110337 | + | ITGAV | chr2 | 187487066 | + |
5UTR-intron | ENST00000304164 | ENST00000474571 | MYO1B | chr2 | 192110337 | + | ITGAV | chr2 | 187487066 | + |
intron-3CDS | ENST00000392316 | ENST00000261023 | MYO1B | chr2 | 192110337 | + | ITGAV | chr2 | 187487066 | + |
intron-3CDS | ENST00000392316 | ENST00000374907 | MYO1B | chr2 | 192110337 | + | ITGAV | chr2 | 187487066 | + |
intron-3CDS | ENST00000392316 | ENST00000433736 | MYO1B | chr2 | 192110337 | + | ITGAV | chr2 | 187487066 | + |
intron-intron | ENST00000392316 | ENST00000474571 | MYO1B | chr2 | 192110337 | + | ITGAV | chr2 | 187487066 | + |
intron-3CDS | ENST00000439065 | ENST00000261023 | MYO1B | chr2 | 192110337 | + | ITGAV | chr2 | 187487066 | + |
intron-3CDS | ENST00000439065 | ENST00000374907 | MYO1B | chr2 | 192110337 | + | ITGAV | chr2 | 187487066 | + |
intron-3CDS | ENST00000439065 | ENST00000433736 | MYO1B | chr2 | 192110337 | + | ITGAV | chr2 | 187487066 | + |
intron-intron | ENST00000439065 | ENST00000474571 | MYO1B | chr2 | 192110337 | + | ITGAV | chr2 | 187487066 | + |
intron-3CDS | ENST00000496992 | ENST00000261023 | MYO1B | chr2 | 192110337 | + | ITGAV | chr2 | 187487066 | + |
intron-3CDS | ENST00000496992 | ENST00000374907 | MYO1B | chr2 | 192110337 | + | ITGAV | chr2 | 187487066 | + |
intron-3CDS | ENST00000496992 | ENST00000433736 | MYO1B | chr2 | 192110337 | + | ITGAV | chr2 | 187487066 | + |
intron-intron | ENST00000496992 | ENST00000474571 | MYO1B | chr2 | 192110337 | + | ITGAV | chr2 | 187487066 | + |
Top |
FusionProtFeatures for MYO1B_ITGAV |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
MYO1B | ITGAV |
Motor protein that may participate in process criticalto neuronal development and function such as cell migration,neurite outgrowth and vesicular transport. {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for MYO1B_ITGAV |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for MYO1B_ITGAV |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
MYO1B | EIF4A2, BRF2, MYC, SIRT7, TCF3, SP1, FBXO25, KIAA0368, CUL1, LRRK2, ATP6V1B1, ESR1, PAN2, RPA3, RPA2, RPA1, CUL7, CCDC8, EGFR, CSNK2A1, DAPK1, NTRK1, PTEN, CAPZA2, CDK2, DBN1, FLNA, MYH9, MYO1C, PPP1CB, PPP1CC, IQGAP1, PDLIM7, SYNPO, LIMA1, ANLN, MYO5C, MYO19, MYO18A, ZNF746, CDH1, STYXL1, NEXN, BCL7C, BCL7A, AVIL, LSP1, CDH5, DKK3, CYLD, DLST, PDHA1 | ITGAV | NOV, ILK, ITGB3, AUP1, L1CAM, CYR61, PLP1, MMP2, CSF1R, CBL, BCAR1, PHKA2, PXN, FBXO6, MCAT, KRT3, FN1, THBS1, EPHA2, TAZ, SUSD4, DPEP2, NTRK1, ITGB1, PSMD12, SPP1, LGALS3BP, FBXW7, MAPK3, NCOR1, NCOR2, EP300, MAPK1, STAT1, SHC1, PTK2, PLA2G2A, ADAM9, ERBB2, ANGPT2, NCL, PAK4, TNFSF13B, LYZL2, NAAA, DEFA1, ST3GAL1, GGH, TMEM25, ST8SIA4, TCTN2, INSL5, FCGR3B, EDIL3, FUT8, PTCH1, B3GNT2, UBC, ITGA4, ITGAV, ITGB5, AGMAT, TRIM25 |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for MYO1B_ITGAV |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | ITGAV | P06756 | DB00098 | Antithymocyte immunoglobulin (rabbit) | Integrin alpha-V | biotech | approved |
Top |
RelatedDiseases for MYO1B_ITGAV |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | MYO1B | C0043094 | Weight Gain | 1 | CTD_human |
Tgene | ITGAV | C0038454 | Cerebrovascular accident | 1 | CTD_human |
Tgene | ITGAV | C2937358 | Cerebral Hemorrhage | 1 | CTD_human |